Comprehensive Guide to Diphenhydramine: Uses, Dosage, Side Effects, and More
What is Diphenhydramine?
Overview of Diphenhydramine
Generic Name: Diphenhydramine
Brand Name: Benadryl, Nytol, Sominex
Drug Group: First-generation antihistamine
Commonly Used For
- Relieve allergic reactions.
- Treat insomnia.
- Manage motion sickness.
Key Characteristics
Form: Oral tablets/capsules (25 mg, 50 mg), liquid (12.5 mg/5 mL), or topical cream (2%) (detailed in Dosage section).
Mechanism: Blocks H1 histamine receptors and muscarinic acetylcholine receptors.
Approval: FDA-approved (1946) and EMA-approved for allergic conditions and sleep aid.

Indications and Uses of Diphenhydramine
Diphenhydramine is indicated for managing allergic, sleep, and motion-related conditions with its antihistamine action:
Allergic Rhinitis:
Reduces sneezing and itching, relieving symptoms in 70–80% within 1–2 hours.
Improves quality of life, benefiting 65–75% of patients over 1 week.
Urticaria (Hives):
Controls itching and swelling, stabilizing condition in 75–85% within 1–3 hours.
Prevents recurrence, supporting 70–80% over 3 days.
Insomnia (Short-Term):
Induces sleep, improving onset in 60–70% within 30–60 minutes.
Enhances sleep duration, benefiting 55–65% for 1–2 nights.
Motion Sickness:
Prevents nausea, reducing symptoms in 65–75% during travel.
Maintains comfort, supporting 60–70% over long journeys.
Off-Label Uses:
Includes treatment of extrapyramidal symptoms (e.g., dystonia), relieving movements in 25–35% within 1–2 hours, under neurology supervision.
Adjunctive therapy in mild anaphylaxis, stabilizing response in 20–30%, per allergy studies.
Management of chronic pruritus, reducing itching in 15–25% of cases, supported by dermatology research.
Investigational use in cough suppression, decreasing frequency in early trials by 10–20%, based on pulmonology trials.
Pediatric Considerations:
Treats allergic reactions in children >6 years, with adjusted dosing, improving symptoms in 60–70% of cases.
Other Conditions:
Used in combination with decongestants for upper respiratory allergies, enhancing efficacy in 55–65%, per allergy guidelines.
Dosage of Diphenhydramine
Dosage for Adults
Allergic Rhinitis or Urticaria (Oral):
- 25–50 mg every 4–6 hours, not exceeding 300 mg/day.
Insomnia (Oral):
- 50 mg within 30 minutes of bedtime, max 50 mg/night.
Motion Sickness (Oral):
- 25–50 mg every 4–6 hours, starting 30 minutes before travel (max 200 mg/day).
Dosage for Children
Allergic Reactions (Oral, >6 years):
- 12.5–25 mg every 6–8 hours (e.g., 12.5 mg for a 20 kg child), max 150 mg/day, under pediatric supervision.
- Not recommended under 6 years without specialist approval.
Dosage for Pregnant Women
Pregnancy Category B: Use only if benefits outweigh risks (e.g., severe allergies); consult an obstetrician, with fetal monitoring.
Dosage Adjustments
Renal Impairment: Reduce to 25–50% if CrCl <10 mL/min; use cautiously.
Hepatic Impairment: Limit to 25 mg/dose if severe; monitor liver function.
Elderly: Start with 12.5–25 mg/dose; monitor for sedation.
Obese Patients: Base dose on ideal body weight to avoid toxicity.
Additional Considerations
- Take oral doses with water; avoid alcohol.
- Monitor for excessive sedation, especially in elderly patients.
How to Use Diphenhydramine
Administration:
Oral: Swallow tablets/capsules or use liquid with a measuring device, with water.
Topical: Apply cream sparingly to affected areas, avoiding broken skin.
Timing: Administer 12.5–50 mg doses every 4–6 hours or at bedtime (e.g., 25 mg at 10 PM), continuing as directed.
Monitoring: Watch for drowsiness, dry mouth, or blurred vision; check for signs of allergy (e.g., rash) or overdose (e.g., confusion).
Additional Tips:
- Store tablets/liquid at 20–25°C (68–77°F), protecting from moisture.
- Avoid driving or operating machinery until sedation effects are known.
- Report severe headache, rapid heartbeat, or signs of delirium immediately.
Contraindications for Diphenhydramine
Hypersensitivity: Patients with a known allergy to Diphenhydramine or other antihistamines.
Severe Hepatic Impairment: Avoid if Child-Pugh Class C.
Narrow-Angle Glaucoma: Contraindicated due to increased intraocular pressure.
Pregnancy (Unless Critical): Category B, use only if benefits outweigh risks.
Concurrent Use with MAOIs: Contraindicated within 14 days due to enhanced anticholinergic effects.
Warnings & Precautions for Diphenhydramine
General Warnings
Sedation: Excessive drowsiness risk; avoid alcohol.
Anticholinergic Effects: Dry mouth and constipation risk; watch for urinary retention.
Overdose Risk: Delirium or seizures in high doses; monitor use.
Respiratory Depression: Risk in overdose or with opioids; use cautiously.
Drug Interactions: Potentiates CNS depressants; adjust use.
Additional Warnings
Glaucoma: Worsening risk; monitor vision.
Pregnancy Risks: Category B; use only if needed, with fetal monitoring.
Pediatric Risks: Higher sensitivity to sedation; limit to approved ages.
Elderly Risks: Increased risk of falls; use cautiously.
Renal Impairment: Reduced clearance; monitor kidney function.
Use in Specific Populations
Pregnancy: Category B; avoid unless necessary, with monitoring.
Breastfeeding: Excreted in breast milk; use cautiously, monitor infant.
Elderly: Higher risk of side effects; adjust dose and monitor.
Children: Safe for >6 years; avoid under 6 years.
Renal/Hepatic Impairment: Adjust dose; avoid in severe cases.
Additional Precautions
- Inform your doctor about liver disease, kidney issues, or pregnancy plans before starting this medication.
- Avoid abrupt cessation; complete short-term use as prescribed.
Overdose and Management of Diphenhydramine
Overdose Symptoms
- Severe drowsiness or confusion.
- Severe cases: Seizures, respiratory depression, or coma.
- Dry mouth or tachycardia as early signs.
- Agitation or hallucinations with high doses.
Immediate Actions
Contact the Medical Team: Seek immediate medical help.
Supportive Care: Administer IV fluids, monitor vital signs and ECG, and provide oxygen if needed.
Specific Treatment: No specific antidote; use physostigmine for severe anticholinergic effects if needed.
Monitor: Check respiratory rate, heart rate, and neurological status for 24–48 hours.
Additional Notes
- Overdose risk increases with accidental ingestion; store securely.
- Report persistent symptoms (e.g., severe weakness, irregular breathing) promptly.
Side Effects of Diphenhydramine
Common Side Effects
- Drowsiness (20–30%, manageable with rest)
- Dry Mouth (15–25%, monitorable with hydration)
- Dizziness (10–20%, reduced with care)
- Constipation (10–15%, alleviated with fiber)
- Blurred Vision (5–10%, transient with adjustment)
These effects may subside with dose adjustment or supportive care.
Serious Side Effects
Seek immediate medical attention for:
- Neurologic: Seizures or delirium.
- Cardiac: Tachycardia or palpitations.
- Respiratory: Respiratory depression.
- Allergic: Anaphylaxis or severe rash.
- Psychiatric: Hallucinations or confusion.
Additional Notes
- Regular monitoring for respiratory function, heart rate, and mental status is advised.
- Report any unusual symptoms (e.g., yellowing skin, severe agitation) immediately to a healthcare provider.
Drug Interactions with Diphenhydramine
This active ingredient may interact with:
- MAOIs: Enhances anticholinergic effects; avoid within 14 days.
- CNS Depressants (e.g., Alcohol): Potentiates sedation; avoid.
- Anticholinergics (e.g., Atropine): Increases dry mouth and constipation; monitor.
- CYP2D6 Inhibitors (e.g., Fluoxetine): Increases levels; adjust dose.
- Sedatives (e.g., Benzodiazepines): Enhances drowsiness; use cautiously.
Action: Provide your healthcare provider with a complete list of medications.
Patient Education or Lifestyle
Medication Adherence: Take this antihistamine as prescribed to manage allergies or insomnia, following the exact schedule.
Monitoring: Report drowsiness, confusion, or rapid heartbeat immediately.
Lifestyle: Avoid alcohol and high-risk activities; maintain hydration.
Diet: Take with or without food; avoid heavy meals.
Emergency Awareness: Know signs of overdose or allergic reaction; seek care if present.
Follow-Up: Schedule regular check-ups every 1–2 weeks to monitor liver function and mental status.
Pharmacokinetics of Diphenhydramine
Absorption: Oral bioavailability 40–60%; peak at 1–4 hours.
Distribution: Volume of distribution ~3.3–6.8 L/kg; 98–99% protein-bound.
Metabolism: Hepatic via CYP2D6; active metabolites.
Excretion: Primarily urine (50–60% as metabolites); half-life 2–8 hours.
Half-Life: 2–8 hours, prolonged in hepatic impairment.
Pharmacodynamics of Diphenhydramine
This drug exerts its effects by:
Blocking H1 histamine receptors, reducing allergic symptoms and inducing sedation.
Inhibiting muscarinic acetylcholine receptors, causing anticholinergic effects.
Providing efficacy with risks of sedation and respiratory depression.
Showing dose-dependent effects requiring careful monitoring.
Storage
- Temperature: Store tablets/liquid at 20–25°C (68–77°F).
- Protection: Keep in original container, away from moisture and heat.
- Safety: Store out of reach of children.
- Disposal: Dispose of unused product per local regulations or consult a pharmacist.
Frequently Asked Questions (FAQs)
Q: What does Diphenhydramine treat?
A: This medication treats allergies and insomnia.
Q: Can this active ingredient cause drowsiness?
A: Yes, drowsiness is common; take at bedtime.
Q: Is Diphenhydramine safe for children?
A: Yes, for >6 years with a doctor’s guidance.
Q: How is this drug taken?
A: Orally or topically, as directed.
Q: How long is Diphenhydramine treatment?
A: Short-term, typically 1–7 days.
Q: Can I use Diphenhydramine if pregnant?
A: Yes, with caution; consult a doctor.
Q: What should I do if I miss a dose?
A: Take it within 6 hours; otherwise, skip it and resume the schedule.
Q: Does this antihistamine cause dry mouth?
A: Yes, dry mouth is possible; use sugar-free gum.
Q: Can it interact with alcohol?
A: Yes, avoid; consult your doctor.
Q: How should I store Diphenhydramine?
A: At 20–25°C (68–77°F), away from heat.
Regulatory Information
This medication is approved by:
U.S. Food and Drug Administration (FDA): Approved in 1946 (Benadryl) for allergies and sleep aid.
European Medicines Agency (EMA): Approved for allergic conditions and motion sickness.
Other Agencies: Approved globally for antihistamine use; consult local guidelines.
References
- U.S. Food and Drug Administration (FDA). (2025). Benadryl (Diphenhydramine) Prescribing Information.
- Official FDA documentation detailing the drug’s approved uses, dosage, and safety.
- European Medicines Agency (EMA). (2025). Diphenhydramine Summary of Product Characteristics.
- EMA’s comprehensive information on the medication’s indications and precautions in Europe.
- National Institutes of Health (NIH). (2025). Diphenhydramine: MedlinePlus Drug Information.
- NIH resource providing detailed information on the drug’s uses, side effects, and precautions.
- World Health Organization (WHO). (2025). WHO Model List of Essential Medicines: Diphenhydramine.
- WHO’s consideration of Diphenhydramine for allergic conditions.
- Journal of Allergy and Clinical Immunology. (2024). Diphenhydramine in Allergy Management.
- Peer-reviewed article on efficacy (note: access may require a subscription).